These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6973504)

  • 1. [Modified E rosette test in patients with malignant ovarian neoplasms].
    Simm S; Tomaszkiewicz T; Markowska J; Kominek P
    Ginekol Pol; 1981 Mar; 52(3):225-30. PubMed ID: 6973504
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of humoral and cellular immunity in the course of ovarian carcinoma].
    Laghi V; Carella G; Burrai I; Sacco F; Margariti PA; Villani L; Benedetti Panici P
    Minerva Ginecol; 1979 Oct; 31(10):737-46. PubMed ID: 317512
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of the measurement of cellular immune status in patients with ovarian malignancies].
    Ma D; Gu MJ
    Zhonghua Fu Chan Ke Za Zhi; 1988 Mar; 23(2):99-101, 128. PubMed ID: 3263914
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular immunologic responsiveness to extracts of ovarian epithelial tumors.
    Melnick H; Barber HR
    Gynecol Oncol; 1975 Mar; 3(1):77-86. PubMed ID: 168133
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunity in patients with malignant ovarian neoplasms].
    Markowska J; Tomaszkiewicz T; Simm S; Jankowiak S
    Ginekol Pol; 1981 Aug; 52(8):729-37. PubMed ID: 6975740
    [No Abstract]   [Full Text] [Related]  

  • 7. [Binding of IgG and IgM class antibodies from the serum of patients with ovarian carcinoma to malignant and normal ovaries].
    Stankus P; Gazárek F
    Cesk Gynekol; 1983 Jun; 48(5):332-8. PubMed ID: 6352065
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of circulating T-lymphocytes in epithelial tumors of the ovary and during chemotherapy].
    Bolis PF; Franchi M; Guaschino S; Maccario R
    Ann Ostet Ginecol Med Perinat; 1982; 103(3):202-5. PubMed ID: 6982650
    [No Abstract]   [Full Text] [Related]  

  • 9. Possibility of immunodiagnosis in ovarian cancer.
    Chin Med J (Engl); 1978 May; 4(3):185-90. PubMed ID: 98299
    [No Abstract]   [Full Text] [Related]  

  • 10. [Correlation of skin tests with the peripheral blood T- and B-lymphocyte tests in malignant ovarian tumors].
    Markowska J; Tomaszkiewicz T; Simm S
    Ginekol Pol; 1980 Aug; 51(8):731-6. PubMed ID: 6968703
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary studies on the effect of Ukrain (Tris(2-([5bS-(5ba,6b,12ba)]- 5b,6,7,12b,13,14-hexahydro-13-methyl[1,3] benzodioxolo[5,6-v]-1-3- dioxolo[4,5-i]phenanthridinium-6-ol]-Ethaneaminyl)Phosphinesulfide.6HCl ) on the immunological response in patients with malignant tumours.
    Danilos J; Zbroja-Sontag W; Baran E; Kurylcio L; Kondratowicz L; Jusiak L
    Drugs Exp Clin Res; 1992; 18 Suppl():55-62. PubMed ID: 1305046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of circulating lung tumor antigen-sensitive T lymphocytes in the early stages of lung cancer.
    Ramey WG; Hashim GA; Munther AS; Swistel AJ; Burrows WB; Fitzpatrick HF
    Surgery; 1980 Aug; 88(2):202-7. PubMed ID: 6967233
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the immune status of patients with cancer of the female genitalia].
    Kis'ov V
    Akush Ginekol (Sofiia); 1991; 30(1):22-4. PubMed ID: 1793132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic function of ovarian cancer].
    Hu XF; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 1985 Mar; 20(2):72-5, 125. PubMed ID: 2988873
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunologic aspects of ovarian tumors].
    Makarov OV; Khashchukoeva AZ; Borisenko SA; Epeĭkina TN; Moiseeva NB
    Akush Ginekol (Mosk); 1988 Nov; (11):3-6. PubMed ID: 3071162
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indicators of cellular immunity in patients with ovarian cancer and methods of their correction].
    Stambrovskaia AA; Siparov IN
    Akush Ginekol (Mosk); 1987 Jul; (7):43-6. PubMed ID: 3688330
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical usefulness of monoclonal antibody, CA 125 and CA 19-9 in ovarian cancer].
    Saitoh S; Nakanishi A; Noda T; Ando Y; Katakami Y; Kiyozuka Y; Moriyama I; Ichijo M
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2327-35. PubMed ID: 6598184
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphocytes isolated from the peritoneal fluid of women with advanced ovarian carcinoma differ significantly from autologous peripheral blood lymphocytes.
    Melioli G; Ferrari I; Casartelli G; Ragni N
    Gynecol Oncol; 1993 Mar; 48(3):301-7. PubMed ID: 8462898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune function in patients with ovarian carcinoma treated with irradiation or with cytostatics.
    Toivanen A; Grönroos M; Lassila O; Nordman E
    Acta Obstet Gynecol Scand; 1984; 63(2):153-8. PubMed ID: 6375243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of breast tumor antigen-sensitive circulating T-lymphocytes by antigen-stimulated active rosette formation.
    Ramey WG; Hashim GA; Burrows WB; Swistel AJ; Munther A; Fitzpatrick HF
    Cancer Res; 1979 Dec; 39(12):4796-801. PubMed ID: 315272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.